Cargando…
Prognostic Role of CD200 in Acute Lymphoblastic Leukemia Patients
Background: Overexpression of CD200 in ALL patients indicates that it may be useful in the characterization of leukemia initiating cells (LIC). We aim at investigating the expression pattern of CD200 on leukemic B cells and the correlation of CD200 expression with various clinical and laboratory fin...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9858047/ https://www.ncbi.nlm.nih.gov/pubmed/36673136 http://dx.doi.org/10.3390/diagnostics13020325 |
_version_ | 1784874001338728448 |
---|---|
author | Khalil, Mohamed Elsharkawy, Nahla Elmawardy, Mona Mohsen Ayoub, Mahmoud Aly |
author_facet | Khalil, Mohamed Elsharkawy, Nahla Elmawardy, Mona Mohsen Ayoub, Mahmoud Aly |
author_sort | Khalil, Mohamed |
collection | PubMed |
description | Background: Overexpression of CD200 in ALL patients indicates that it may be useful in the characterization of leukemia initiating cells (LIC). We aim at investigating the expression pattern of CD200 on leukemic B cells and the correlation of CD200 expression with various clinical and laboratory findings in 62 newly diagnosed acute lymphoblastic leukemia patients. Methods: All patients were subjected to full history taking, a thorough clinical examination, and laboratory investigations, which included complete blood count (CBC), BM aspiration, immunophenotyping of blast cells, and CD200 expression. Results: There is a higher statistically significant mean value of CD200 expression among the cases (66.15 ± 23.08) than the control group (0.37 ± 0.2) (p value ≤ 0.001). CD200 expression shows a significant correlation with total leucocytic count and hemoglobin level (p = 0.001, 0.03, respectively). Conclusions: This study showed that CD200 expression was expressed in 100% of the patients. Correlations between CD200 expression and different laboratory data of patients revealed that there was an impact of CD200 on different diagnostic findings. After the follow-up of the patients, we found that the use of PRISM function of the software could add value to the detection of minimal residual disease. |
format | Online Article Text |
id | pubmed-9858047 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-98580472023-01-21 Prognostic Role of CD200 in Acute Lymphoblastic Leukemia Patients Khalil, Mohamed Elsharkawy, Nahla Elmawardy, Mona Mohsen Ayoub, Mahmoud Aly Diagnostics (Basel) Article Background: Overexpression of CD200 in ALL patients indicates that it may be useful in the characterization of leukemia initiating cells (LIC). We aim at investigating the expression pattern of CD200 on leukemic B cells and the correlation of CD200 expression with various clinical and laboratory findings in 62 newly diagnosed acute lymphoblastic leukemia patients. Methods: All patients were subjected to full history taking, a thorough clinical examination, and laboratory investigations, which included complete blood count (CBC), BM aspiration, immunophenotyping of blast cells, and CD200 expression. Results: There is a higher statistically significant mean value of CD200 expression among the cases (66.15 ± 23.08) than the control group (0.37 ± 0.2) (p value ≤ 0.001). CD200 expression shows a significant correlation with total leucocytic count and hemoglobin level (p = 0.001, 0.03, respectively). Conclusions: This study showed that CD200 expression was expressed in 100% of the patients. Correlations between CD200 expression and different laboratory data of patients revealed that there was an impact of CD200 on different diagnostic findings. After the follow-up of the patients, we found that the use of PRISM function of the software could add value to the detection of minimal residual disease. MDPI 2023-01-16 /pmc/articles/PMC9858047/ /pubmed/36673136 http://dx.doi.org/10.3390/diagnostics13020325 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Khalil, Mohamed Elsharkawy, Nahla Elmawardy, Mona Mohsen Ayoub, Mahmoud Aly Prognostic Role of CD200 in Acute Lymphoblastic Leukemia Patients |
title | Prognostic Role of CD200 in Acute Lymphoblastic Leukemia Patients |
title_full | Prognostic Role of CD200 in Acute Lymphoblastic Leukemia Patients |
title_fullStr | Prognostic Role of CD200 in Acute Lymphoblastic Leukemia Patients |
title_full_unstemmed | Prognostic Role of CD200 in Acute Lymphoblastic Leukemia Patients |
title_short | Prognostic Role of CD200 in Acute Lymphoblastic Leukemia Patients |
title_sort | prognostic role of cd200 in acute lymphoblastic leukemia patients |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9858047/ https://www.ncbi.nlm.nih.gov/pubmed/36673136 http://dx.doi.org/10.3390/diagnostics13020325 |
work_keys_str_mv | AT khalilmohamed prognosticroleofcd200inacutelymphoblasticleukemiapatients AT elsharkawynahla prognosticroleofcd200inacutelymphoblasticleukemiapatients AT elmawardymonamohsen prognosticroleofcd200inacutelymphoblasticleukemiapatients AT ayoubmahmoudaly prognosticroleofcd200inacutelymphoblasticleukemiapatients |